Yarrow Bioscience, Inc.
YARW· Nasdaq
Released Aug 1, 2018, after the close
10-Q filed Aug 1, 2018, 32 days after period end · 0001564590-18-018481
| Metric | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|
| Revenue | $10.14M | $449.00K | — |
| Net Income | -$8.35M | -$6.15M | -$3.56M |
| EPS Diluted | -$0.36 | -$1.21 | -$0.72 |
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.